Treatment guidelines in polycythemia vera currently recommend maintaining hematocrit below 45%, with a higher threshold for men vs women. Treatment guidelines in PV currently recommend maintaining ...
SAN DIEGO -- A novel therapy for polycythemia vera (PCV) maintained stable hematocrit levels for as long as 2.5 years and significantly reduced use of phlebotomy, a small randomized trial showed. The ...
Data suggest a substantial reliance on established therapies for polycythemia vera, despite access to all available treatment options. Currently available treatments for polycythemia vera (PV) may not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results